Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Essen Biotech
MacroGenics
Indiana University
City of Hope Medical Center
University of Florida
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
University of Southern California
Swiss Cancer Institute
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Transgene
HiFiBiO Therapeutics
Seattle Children's Hospital
Bayer
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Hadassah Medical Organization
British Columbia Cancer Agency
Valo Therapeutics Oy
Guangzhou FineImmune Biotechnology Co., LTD.
Fudan University
Institut Claudius Regaud
University of Pittsburgh
Iovance Biotherapeutics, Inc.
Eli Lilly and Company
Centre Hospitalier Universitaire Vaudois
Stanford University
Cedars-Sinai Medical Center
Stanford University
GI Innovation, Inc.